Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar

Wellcome Open Research

Volumn 2, Issue , 2017, Pages

  Landier, Jordi ^a   Kajeechiwa, Ladda ^a   Thwin, May Myo ^a   Parker, Daniel M ^a   Chaumeau, Victor ^a,b,c   Wiladphaingern, Jacher ^a   Imwong, Mallika ^d   Miotto, Olivo ^d,e,f   Patumrat, Krittaya ^d   Duanguppama, Jureeporn ^d   Cerqueira, Dominique ^d   Malleret, Benoit ^g,h   Rénia, Laurent ^h   Nosten, Suphak ^a   Von Seidlein, Lorenz ^d   Ling, Clare ^a   Proux, Stéphane ^a   Corbel, Vincent ^b   Simpson, Julie A ⁱ   Dondorp, Arjen M ^d,j   White, Nicholas J ^d,j   Nosten, François H ^a,j   more..

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h AGENCY FOR SCIENCE   (Singapore)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85039147984     PISSN: None     EISSN: 2398502X     Source Type: Journal    
DOI: 10.12688/wellcomeopenres.12240.1     Document Type: Article

References (26)

1. White NJ, Pukrittayakamee S, Hien TT, et al.: Malaria. Lancet. 2014; 383(9918): 723–35.
2. Ashley EA, Dhorda M, Fairhurst RM, et al.: Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371(5): 411–23.
3. Phyo AP, Ashley EA, Anderson TJC, et al.: Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003–2013): The Role of Parasite Genetic Factors. Clin Infect Dis. 2016; 63(6): 784–791.
4. Amaratunga C, Lim P, Suon S, et al.: Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: A multisite prospective cohort study. Lancet Infect Dis. 2016; 16(3): 357–65.
5. Barnes KI, Chanda P, Ab Barnabas G: Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J. 2009; 8(suppl 1): S8.
6. Carrara VI, Sirilak S, Thonglairuam J, et al.: Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med. 2006; 3(6): e183.
7. Landier J, Parker DM, Thu AM, et al.: The role of early detection and treatment in malaria elimination. Malar J. BioMed Central; 2016; 15: 363.
8. Imwong M, Stepniewska K, Tripura R, et al.: Numerical Distributions of Parasite Densities During Asymptomatic Malaria. J Infect Dis. 2016; 213(8): 1322–9.
9. Imwong M, Nguyen TN, Tripura R, et al.: The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J. BioMed Central; 2015; 14: 381.
10. von Seidlein L, Dondorp A: Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015; 13(6): 715–30.
11. Lwin KM, Imwong M, Suangkanarat P, et al.: Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J. BioMed Central; 2015; 14: 319.
12. Cook J, Xu W, Msellem M, et al.: Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis. 2015; 211(9): 1476–83.
13. Newby G, Hwang J, Koita K, et al.: Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015; 93(1):
14. Dicko A, Brown JM, Diawara H, et al.: Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial. Lancet Infect Dis. 2016; 16(6): 674–84.
15. Eisele TP, Bennett A, Silumbe K, et al.: Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial. J Infect Dis. 2016; 214(12): 1831–1839.
16. Phyo AP, Nkhoma S, Stepniewska K, et al.: Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet. Elsevier Ltd; 2012; 379(9830): 1960–1966.
17. Carrara VI, Lwin KM, Phyo AP, et al.: Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med. 2013; 10(3): e1001398.
18. Cheah PY, Lwin KM, Phaiphun L, et al.: Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt. Int Health. 2010; 2(2): 123–9.
19. Kajeechiwa L, Thwin MM, Nosten S, et al.: Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar [version 1; referees: 1 approved]. Wellcome Open Res. 2017; 2: 59.
20. Kajeechiwa L, Thwin MM, Shee PW, et al.: The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016; 15(1): 494.
21. Imwong M, Hanchana S, Malleret B, et al.: High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014; 52(9): 3303–9.
22. Amato R, Lim P, Miotto O, et al.: Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2017; 17(2): 164–173.
23. Kwansomboon N, Chaumeau V, Kittiphanakun P, et al.: Vector bionomics and malaria transmission along the Thailand-Myanmar border: a baseline entomological survey. J Vector Ecol. 2017; 42(1): 84–93.
24. Ya-umphan P, Cerqueria D, Parker DM, et al.: Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border. J Infect Dis. 2017; 215(3): 396–404.
25. Chaumeau V, Andolina C, Fustec B, et al.: Comparison of the Performances of Five Primer Sets for the Detection and Quantification of Plasmodium in Anopheline Vectors by Real-Time PCR. PLoS One. 2016; 11(7): e0159160.
26. Bancone G, Chowwiwat N, Somsakchaicharoen R, et al.: Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects. PLoS One. 2016; 11(3): e0151898.